| Literature DB >> 35522470 |
Rayner Kay Jin Tan1,2, Wee Ling Koh1, Daniel Le3, Sumita Banerjee3, Martin Tze-Wei Chio4, Roy Kum Wah Chan5, Christina Misa Wong6, Bee Choo Tai1, Mee Lian Wong1, Alex R Cook1, Mark I-Cheng Chen7, Chen Seong Wong7.
Abstract
BACKGROUND: Gay, bisexual, and other men who have sex with men (GBMSM) are at disproportionately higher risk of acquiring HIV and other sexually transmitted infections (STI). While HIV/STI testing rates among GBMSM are increasing worldwide, they remain suboptimal in a variety of settings. While many studies have attempted to evaluate the efficacy of a variety of community-based campaigns, including peer and reminder-based interventions on HIV/STI testing, however few have attempted to do so for a web drama series.Entities:
Keywords: HIV; STI; eHealth; health promotion; mHealth; testing
Mesh:
Year: 2022 PMID: 35522470 PMCID: PMC9123545 DOI: 10.2196/31401
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Figure 1Consolidated Standards of Reporting Trials diagram.
Demographic characteristics and outcome variables for control and intervention groups.
| Demographic and outcome variables at baseline | Control (n=150) | Intervention (n=150) | |||
|
| |||||
|
| Age (year), mean (SD) | 23.8 (2.99) | 24.0 (2.98) | ||
|
| Chinese (ref: non-Chinese), n (%) | 124 (82.7) | 113 (75.3) | ||
|
| Gay (ref: bisexual, queer, or other), n (%) | 127 (84.7) | 116 (77.3) | ||
|
| Educational attainment below college (ref: some college), n (%) | 95 (63.3) | 92 (61.3) | ||
|
| Public housing (ref: private housing), n (%) | 112 (74.7) | 126 (84.0) | ||
|
| Monthly income below SGDa 5000 (ref: SGD 5000 and above), n (%) | 82 (54.7) | 73 (48.7) | ||
|
| |||||
|
| Ever tested for HIV, n (%) | 113 (75.3) | 108 (72.0) | ||
|
| Ever tested for syphilis, n (%) | 73 (48.7) | 77 (51.3) | ||
|
| Ever tested for chlamydia or gonorrhea, n (%) | 55 (36.7) | 59 (39.3) | ||
|
| Tested for HIV in last 6 months, n (%) | 66 (44.0) | 63 (42.0) | ||
|
| Tested for syphilis in last 6 months, n (%) | 39 (26.0) | 41 (27.3) | ||
|
| Tested for chlamydia or gonorrhea in last 6 months, n (%) | 21 (14.0) | 26 (17.3) | ||
|
| Tested regularly (at least yearly) for HIV, n (%) | 68 (45.3) | 68 (45.3) | ||
|
| Tested regularly (at least yearly) for syphilis, n (%) | 37 (24.7) | 44 (29.3) | ||
|
| Tested regularly (at least yearly) for chlamydia or gonorrhea, n (%) | 28 (18.7) | 34 (22.7) | ||
|
| Intention to test for HIV in the next 3 months, n (%) | 56 (37.3) | 59 (39.3) | ||
|
| Intention to test for syphilis in the next 3 months, n (%) | 41 (27.3) | 39 (26.0) | ||
|
| Intention to test for chlamydia or gonorrhea in the next 3 months, n (%) | 33 (22.0) | 33 (22.0) | ||
aSGD: Singapore dollar.
Comparison of primary outcome measures at 6 months postintervention.
| Primary outcome variables | Control (n=123), n (%) | Intervention (n=109), n (%) | Difference, % | 95% CI | |
| Ever tested for HIV | 95 (77.2) | 83 (76.2) | –1.1 | –11.9 to 9.9 | .85 |
| Ever tested for syphilis | 64 (52.0) | 69 (63.3) | 11.3 | –1.4 to 24.0 | .08 |
| Ever tested for chlamydia and gonorrhea | 51 (41.5) | 56 (51.4) | 9.9 | –2.9 to 22.7 | .13 |
| Tested for HIV in last 6 months | 41 (33.3) | 42 (38.5) | 5.2 | –7.1 to 17.5 | .41 |
| Tested for syphilis in last 6 months | 31 (25.2) | 30 (27.5) | 2.3 | –9.0 to 13.6 | .69 |
| Tested for chlamydia and gonorrhea in last 6 months | 22 (17.9) | 25 (22.9) | 5.1 | –5.3 to 15.3 | .34 |
| Tested regularly (at least yearly) for HIV | 55 (44.7) | 66 (60.6) | 15.8 | 3.2 to 28.6 | .02 |
| Tested regularly (at least yearly) for syphilis | 36 (29.3) | 43 (39.5) | 10.2 | –2.0 to 22.4 | .10 |
| Tested regularly (at least yearly) for chlamydia and gonorrhea | 25 (20.3) | 39 (35.8) | 15.5 | 4.2 to 26.9 | .009 |
| Intention to test for HIV in the next 3 months | 36 (29.3) | 50 (45.9) | 16.6 | 4.3 to 28.9 | .009 |
| Intention to test for syphilis in the next 3 months | 28 (22.8) | 41 (37.6) | 14.8 | 3.2 to 26.4 | .01 |
| Intention to test for chlamydia and gonorrhea in the next 3 months | 24 (19.5) | 38 (34.9) | 15.4 | 4.2 to 26.6 | .008 |
Figure 2Trends in ever testing and recent testing for HIV and other sexually transmitted infections in control and intervention arms. High-resolution version of the figure is in Multimedia Appendix 2.
Figure 3Trends in being a regular (at least yearly) tester and intention to test for HIV and other sexually transmitted infections in control and intervention arms. High-resolution version of the figure is in Multimedia Appendix 3.
Comparison of secondary outcome measures at 6 months postintervention.
| Secondary outcome variables | Control (n=123), median (IQR) | Intervention (n=109), median (IQR) | Differencea, % | 95% CIa | |
| Perceived HIV risk, median (IQR) | 2.0 (15.0) | 6.0 (20.0) | 0 | 0-0 | .32 |
| Perceived risk of other sexually transmitted infections, median (IQR) | 5.0 (20.0) | 8.0 (25.0) | 0 | 0-0 | .49 |
| HIV and other sexually transmitted infections knowledge, median (IQR) | 6.0 (2.0) | 6.0 (1.0) | 0 | 0-0 | .08 |
| Knowledge of HIV postexposure prophylaxis, n (%) | 113 (91.9) | 103 (94.5) | 2.6 | –3.9 to 9.1 | .43 |
| Knowledge of HIV preexposure prophylaxis, n (%) | 122 (99.2) | 107 (98.2) | –1.0 | –3.9 to 1.9 | .49 |
| Inconsistent condom use in last 6 months with casual partners, n (%) | 20 (16.3) | 15 (13.8) | –2.5 | –11.7 to 6.7 | .60 |
| Incidence of sexually transmitted infections in last 6 months, n (%) | 8.0 (6.5) | 4.0 (3.7) | –2.8 | –8.4 to 2.8 | .33 |
| Connectedness to the lesbian, gay, bisexual, and transgender community, median (IQR) | 22.0 (5.0) | 21.0 (6.0) | 1 | –2.0 to 1.0 | .35 |
| Self-concealment of sexual orientation, median (IQR) | 19.0 (10.0) | 20.0 (9.0) | –1.0 | –3.0 to 1.0 | .30 |
| Outness inventory, median (IQR) | 2.74 (1.88) | 2.33 (1.88) | 0.1 | –0.2 to 0.4 | .45 |
| Disclosure of sexual orientation to health care provider, median (IQR) | 25.0 (8.0) | 23.0 (9.0) | 1 | 0 to 3.0 | .17 |
| Perceived homophobia, median (IQR) | 18.0 (4.0) | 18.0 (4.0) | 0 | –1.0 to 1.0 | .94 |
| Internalized homophobia, median (IQR) | 10.0 (6.0) | 10.0 (5.0) | 0 | –1.0 to 1.0 | .56 |
| HIV self-testing efficacy, median (IQR) | 38.0 (11.0) | 36.0 (11.0) | 0 | –2.0 to 2.0 | .76 |
| HIV testing social norms, median (IQR) | 22.0 (4.0) | 22.0 (4.0) | 0 | –1.0 to 0 | .28 |
aMedian differences between the groups and 95% CIs were estimated with the Hodges-Lehmann method.
bP value is derived from the Wilcoxon rank-sum test.